Literature DB >> 19542002

Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells.

M Soledad Saldías1, Miguel A Valvano.   

Abstract

Burkholderia cenocepacia is a member of the B. cepacia complex (Bcc), a group of opportunistic bacteria that infect the airways of patients with cystic fibrosis (CF) and are extraordinarily resistant to almost all clinically useful antibiotics. Infections in CF patients with Bcc bacteria generally lead to a more rapid decline in lung function, and in some cases to the 'cepacia syndrome', a virtually deadly exacerbation of the lung infection with systemic manifestations. These characteristics of Bcc bacteria contribute to higher morbidity and mortality in infected CF patients. In the last 10 years considerable progress has been made in understanding the interactions between Bcc bacteria and mammalian host cells. Bcc isolates can survive either intracellularly within eukaryotic cells or extracellularly in host tissues. They survive within phagocytes and respiratory epithelial cells, and they have the ability to breach the respiratory epithelium layer. Survival and persistence of Bcc bacteria within host cells and tissues are believed to play a key role in pulmonary infection and to contribute to the persistent inflammation observed in patients with CF. This review summarizes recent findings concerning the interaction between Bcc bacteria and epithelial and phagocytic cells.

Entities:  

Mesh:

Year:  2009        PMID: 19542002     DOI: 10.1099/mic.0.031344-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  28 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.

Authors:  Ute Schwab; Lubna H Abdullah; Olivia S Perlmutt; Daniel Albert; C William Davis; Roland R Arnold; James R Yankaskas; Peter Gilligan; Heiner Neubauer; Scott H Randell; Richard C Boucher
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection.

Authors:  Annette C Vergunst; Annemarie H Meijer; Stephen A Renshaw; David O'Callaghan
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

4.  Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay.

Authors:  Mohamad A Hamad; Alexander M Skeldon; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

5.  Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia.

Authors:  Mikhail A Gavrilin; Dalia H A Abdelaziz; Mahmoud Mostafa; Basant A Abdulrahman; Jaykumar Grandhi; Anwari Akhter; Arwa Abu Khweek; Daniel F Aubert; Miguel A Valvano; Mark D Wewers; Amal O Amer
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

6.  Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions.

Authors:  M Guadalupe Cabral; Marília Pereira; Zélia Silva; Inês Iria; Carla Coutinho; Andreia Lopes; Isabel Sá-Correia; Paula A Videira
Journal:  Med Microbiol Immunol       Date:  2016-12-16       Impact factor: 3.402

7.  Depletion of the ubiquitin-binding adaptor molecule SQSTM1/p62 from macrophages harboring cftr ΔF508 mutation improves the delivery of Burkholderia cenocepacia to the autophagic machinery.

Authors:  Basant A Abdulrahman; Arwa Abu Khweek; Anwari Akhter; Kyle Caution; Mia Tazi; Hoda Hassan; Yucheng Zhang; Patrick D Rowland; Sankalp Malhotra; Famke Aeffner; Ian C Davis; Miguel A Valvano; Amal O Amer
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

8.  The tyrosine kinase BceF and the phosphotyrosine phosphatase BceD of Burkholderia contaminans are required for efficient invasion and epithelial disruption of a cystic fibrosis lung epithelial cell line.

Authors:  Ana S Ferreira; Inês N Silva; Fábio Fernandes; Ruth Pilkington; Máire Callaghan; Siobhán McClean; Leonilde M Moreira
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

9.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual.

Authors:  Suman S Karanth; Hariharan Regunath; Kiran Chawla; Mukhyaprana Prabhu
Journal:  Asian Pac J Trop Biomed       Date:  2012-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.